John L. Brooks
Director, Pathfinder Cell Therapy, Inc.
Companies
- iSpecimen Inc.Board member Jun 17, 2021 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- iSpecimen Inc. ISPC3,250 shares2$3.3K at $1.03Jan 1, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 1, 2023Granted 125 shares of iSpecimen Inc.2
- Oct 1, 2022Granted 625 shares of iSpecimen Inc.3
- Jul 30, 2021Granted 2,500 shares of iSpecimen Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARiSpecimen Inc., Board member
- 2
- 3SEC EDGARForm 5 filed Feb 10, 2023
- 4SEC EDGARForm 5 filed Feb 14, 2022